Evidence map›Paper›PMID 30202043›Full record

ArticleScientific reports2018

Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model.

Younghyun Lee, Monica Pujol Canadell, Igor Shuryak, Jay R Perrier, Maria Taveras, Purvi Patel, Antonius Koller, Lubomir B Smilenov, David J Brenner, Emily I Chen and 1 more

Open access · goldAbstract readValidation Study
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The NIAID/RNCP Biodosimetry Program: An Overview.Cytogenetic and genome research · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Dose Variations Using an X-Ray Cabinet to EstablishFrontiers in public health · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Younghyun LeeCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA. younghyun.lee.0123@gmail.com.ORCID 0000-0003-0633-7248
Monica Pujol CanadellCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA.
Igor ShuryakCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA.
Jay R PerrierCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA.
Maria TaverasCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA.
Purvi PatelHerbert Irving Comprehensive Cancer Center, Proteomics Shared Resource, Columbia University Medical Center, New York, NY, 10032, USA.
Antonius KollerHerbert Irving Comprehensive Cancer Center, Proteomics Shared Resource, Columbia University Medical Center, New York, NY, 10032, USA.
Lubomir B SmilenovCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA.
David J BrennerCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA.
Emily I ChenHerbert Irving Comprehensive Cancer Center, Proteomics Shared Resource, Columbia University Medical Center, New York, NY, 10032, USA.
Helen C TurnerCenter for Radiological Research, Columbia University Medical Center, New York, NY, 10032, USA. ht2231@cumc.columbia.edu.
Columbia University Irving Medical Center · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FORNACE, ALBERT J · 2005 to 2024
$105.4M
NCI NIH HHS P30 CA013696NIAID NIH HHS U19 AI067773
6 · The paper itself

Abstract

After a radiological incident, there is an urgent need for fast and reliable bioassays to identify radiation-exposed individuals within the first week post exposure. This study aimed to identify candidate radiation-responsive protein biomarkers in human lymphocytes in vivo using humanized NOD scid gamma (Hu-NSG) mouse model. Three days after X-irradiation (0-2 Gy, 88 cGy/min), human CD45+ lymphocytes were collected from the Hu-NSG mouse spleen and quantitative changes in the proteome of the human lymphocytes were analysed by mass spectrometry. Forty-six proteins were differentially expressed in response to radiation exposure. FDXR, BAX, DDB2 and ACTN1 proteins were shown to have dose-dependent response with a fold change greater than 2. When these proteins were used to estimate radiation dose by linear regression, the combination of FDXR, ACTN1 and DDB2 showed the lowest mean absolute errors (≤0.13 Gy) and highest coefficients of determination (R

Indexed as

Dose-Response Relationship, RadiationActininAnimalsbcl-2-Associated X ProteinBiomarkersCells, CulturedCord Blood Stem Cell TransplantationDisease Models, AnimalDNA-Binding ProteinsFemaleFerredoxin-NADP ReductaseGene Expression RegulationHealthy VolunteersHumansLymphocytesMiceActininACTN1 protein, humanBAX protein, humanbcl-2-Associated X ProteinBiomarkersDDB2 protein, humanDNA-Binding ProteinsFerredoxin-NADP Reductase

Identifiers

PMID30202043
PMCPMC6131502
OpenAlexW2891787477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.